GSK (NYSE:GSK) (LON:GSK) said on Monday that the U.S. Food and Drug Administration has accepted its priority review ...

Chasing a 100 times return might not be a great idea. But there are lessons to be taken from past winners of this magnitude.

Arvinas, in collaboration with Pfizer, has announced vepdegestrant NDA acceptance by the FDA for breast cancer treatment.

The U.S. Department of Health and Human Services (HHS) has announced a sweeping plan to wind down its mRNA vaccine ...

Here are two beaten-down stocks that long-term investors might want to consider buying on the dip and holding for several ...

Pfizer ( PFE) shares gained on Tuesday after the New York-based pharma giant reported better-than-expected financials for Q2 2025 and increased its full-year earnings outlook, citing, among other ...

Here is why Pfizer's newfound momentum could set the stock up to soar in 2026. Pfizer's generous dividend has become a big ...